Standard Operating Procedure for Handling Labeling and Safety-Related Regulatory Questions
| Department | Regulatory Affairs |
| SOP No. | RA/2026/732 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This SOP defines the standardized process for handling labeling and safety-related regulatory questions received from health authorities or other regulatory stakeholders. Its objective is to ensure timely, accurate, and compliant responses in alignment with applicable regulatory requirements and company quality systems, thereby maintaining product safety integrity and regulatory compliance throughout the product lifecycle.
Scope
This procedure applies to all labeling and safety-related queries arising from health authority inspections, submissions, deficiency letters, or post-marketing surveillance for all pharmaceutical products, dosage forms, and medical devices under the jurisdiction of Regulatory Affairs. It covers receipt, evaluation, coordination, response preparation, review, approval, and submission of replies. Queries unrelated to labeling or safety issues, or outside regulatory communication channels, are excluded.
Responsibilities
- Regulatory Affairs Coordinator: To receive and log incoming queries, coordinate internal inputs, and prepare draft responses.
- Subject Matter Experts (e.g., Safety, Labeling, Quality Assurance): To provide technical evaluation and data support required for response development.
- Quality Assurance: To review for compliance adherence and approve final response documents.
- Regulatory Affairs Head: To oversee process execution, ensure regulatory timelines are met, and authorize submission of responses.
- Documentation Control: To maintain controlled records of all communications and related regulatory documents.
Accountability
The Head of Regulatory Affairs is accountable for full implementation, compliance monitoring, periodic review, escalation of issues, and ensuring the ongoing effectiveness of this SOP. They are responsible for ensuring all responses meet regulatory expectations and internal quality standards.
Procedure
1. Receipt and Logging: Upon receipt of a labeling or safety-related query from a health authority, the Regulatory Affairs Coordinator shall log the correspondence into the regulatory communication tracking system, recording date of receipt, query reference, and deadlines.
2. Preliminary Review: The Coordinator shall perform an initial assessment to categorize the query type and urgency, and assign relevant internal departments (e.g., Safety, Labeling, QA) for technical input.
3. Gathering Information: Subject Matter Experts shall collect all pertinent data, reports, and evidence needed to address the query comprehensively. This may include review of labeling texts, safety databases, stability data, manufacturing records, or clinical information as applicable.
4. Draft Response Preparation: Regulatory Affairs shall integrate all inputs into a consolidated, clear, and accurate draft response. The draft must adhere to agreed templates and comply with regulatory language standards and confidentiality requirements.
5. Internal Review and Approval: The draft response shall be routed to QA for compliance verification and the Regulatory Affairs Head for final approval. Any necessary clarifications or revisions shall be addressed promptly.
6. Submission: Once approved, the Regulatory Affairs Coordinator shall submit the response to the relevant health authority within the stipulated timeline, ensuring a confirmation of receipt is obtained and documented.
7. Documentation and Record Retention: All correspondence, draft versions, approvals, and submission confirmations shall be archived in the controlled documentation system for future reference and regulatory inspections. Record retention shall follow company policy and regulatory mandates.
8. Follow-up and Closure: Post-submission, the Regulatory Affairs team shall monitor for any further health authority communications or feedback and ensure timely action. The query shall be formally closed once a satisfactory resolution or confirmation is received.
9. Deviation and Escalation: In case of deviations from this process, significant delays, or issues impacting product safety or compliance, immediate escalation to the Regulatory Affairs Head and Quality Assurance shall occur, alongside documentation of the deviation and corrective actions.
Abbreviations
- QA – Quality Assurance
- RA – Regulatory Affairs
- GMP – Good Manufacturing Practices
- SME – Subject Matter Expert
- HDA – Health Authority Documentation
Documents
- Regulatory Query Log and Tracking Form (Annexure-1)
- Labeling and Safety Query Response Template (Annexure-2)
- Health Authority Correspondence Archive Sheet (Annexure-3)
References
- ICH Q7 Good Manufacturing Practice Guide
- FDA and EMA Guidelines on Labeling and Post-market Safety Surveillance
- Company Quality Management System Documentation Control Procedures
- Applicable regional regulatory authority communication and response policies
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Query Log and Tracking Form
Purpose: To systematically record and track labeling and safety-related queries received from health authorities, capturing essential details and monitoring response timelines.
| Field | Details (Example) |
|---|---|
| Query Reference Number | HAQ-2026-045 |
| Date Received | 10/04/2026 |
| Health Authority Name | European Medicines Agency (EMA) |
| Product Name/Code | Product XYZ – Batch #1234 |
| Query Type | Labeling – Safety Warning Clarification |
| Deadline for Response | 24/04/2026 |
| Assigned Department(s) | Labeling, Safety, QA |
| Current Status | In Progress |
| Comments | Awaiting safety data input |
Annexure-2: Labeling and Safety Query Response Template
Purpose: To provide a consistent format for compiling and submitting responses to health authority queries related to labeling and safety issues.
| To: | European Medicines Agency (EMA) |
| From: | Regulatory Affairs Department |
| Date: | 22/04/2026 |
| Subject: | Response to Query Reference HAQ-2026-045 – Labeling and Safety Clarifications for Product XYZ |
| Response Summary: Following a detailed review of safety data and label text, we confirm that revisions have been made to the warning section to enhance clarity, in compliance with your recommendations. Attached are supporting safety reports and updated labeling samples. |
|
| Attachments: |
|
| Prepared By: | Regulatory Affairs Coordinator |
| Reviewed By: | Quality Assurance |
| Approved By: | Head of Regulatory Affairs |
Annexure-3: Health Authority Correspondence Archive Sheet
Purpose: To maintain a controlled record of all correspondence and responses related to regulatory labeling and safety queries for audit and inspection purposes.
| Date | Document Type | Description | Version | Controlled Document ID | Storage Location |
|---|---|---|---|---|---|
| 10/04/2026 | Query Letter | Labeling and safety question from EMA | 1.0 | RA-CORR-2026-1001 | Regulatory Archives, Folder RAQ-2026 |
| 22/04/2026 | Response Letter | Official reply with labeling revisions | 1.0 | RA-CORR-2026-1002 | Regulatory Archives, Folder RAQ-2026 |
| 22/04/2026 | Supporting Documents | Safety data report and updated label | 1.0 | RA-DOC-2026-205 | Regulatory Document Management System |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |